U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07774455) titled 'Pacritinib Effectiveness in Real-world Settings' on July 22.

Brief Summary: This study aims to evaluate real-world treatment patterns and effectiveness of pacritinib, including hematologic and clinical outcomes, and survival through a site-based retrospective chart review of medical records of patients with MF.

Study Start Date: Aug. 01

Study Type: OBSERVATIONAL

Condition: Myelofibrosis (MF)

Intervention: OTHER: Not applicable- observational study

Not Applicable - Observational Study

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Swedish Orphan Biovitrum

Disclaimer: Curated by HT Syndication....